Zobrazeno 1 - 10 of 883 pro vyhledávání: '"HUGHES, DA"'
3
Lysosomal Acid Lipase Deficiency: Therapeutic Options
Autor: Pastores GM, Hughes DA
Publikováno v: Drug Design, Development and Therapy, Vol Volume 14, Pp 591-601 (2020)
Gregory M Pastores,1 Derralynn A Hughes2 1Department of Medicine (Genetics)/National Centre for Inherited Metabolic Disorders, Mater Misericordiae University Hospital and University College Dublin, Dublin, Ireland; 2Royal Free London NHS Foundation T
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::720d778217371918cbf55d15a98f4299
https://www.dovepress.com/lysosomal-acid-lipase-deficiency-therapeutic-options-peer-reviewed-article-DDDT
Zobrazit plný text záznamu
4
Methodological considerations on estimating medication adherence from self-report, electronic monitoring and electronic healthcare databases using the TEOS framework
Autor: Dima AL, Allemann SS, Dunbar-Jacob J, Hughes DA, Vrijens B, Wilson IB
Publikováno v: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Aims Measuring adherence to medication is complex due to the diversity of contexts in which medications are prescribed, dispensed and used. The Timelines-Events-Objectives-Sources (TEOS) framework outlined a process to operationalize adherence. We ai
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::4f757ea524c7e80ca6d6f8c12d10d2a2
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=21475
Zobrazit plný text záznamu
6
TEOS: A framework for constructing operational definitions of medication adherence based on Timelines-Events-Objectives-Sources
Autor: Dima AL, Allemann SS, Dunbar-Jacob J, Hughes DA, Vrijens B, Wilson IB
Publikováno v: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
AIMS: Managing adherence to medications is a priority for health systems worldwide. Adherence research is accumulating, yet the quality of the evidence is reduced by various methodological limitations. In particular, the heterogeneity and low accurac
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::6f87416f99685090c497f63b48a67db1
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20588
Zobrazit plný text záznamu
8
Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey
Autor: Elliott P, Baker R, Quarta G, Ebrahim H, Mehta AB, Hughes DA, ACES study group, Anastasakis A, Autore C, Musumeci MB, Frenneaux M, Gimeno J, Tiina H, Kuusisto J, Aalto Setäla K, McKeown P, Monserrat L, Fernandez X, Pacileo G, Limongelli G, Cate FJ, Wilde AA, Pinto YM, Christiaans I, Zachara E., PASQUALE, FERDINANDO, RAPEZZI, CLAUDIO, BIAGINI, ELENA
Publikováno v: Heart (British Cardiac Society), 97(23), 1957-1960. BMJ Publishing Group
Objectives The prevalence of Anderson–Fabry disease (AFD) in patients presenting with unexplained left ventricular hypertrophy (LVH) is controversial. The aim of this study was to determine the prevalence of AFD in a large, consecutive cohort of pa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::202cb8d96e9c85e25d1ce9abb832e934
https://doi.org/10.1136/heartjnl-2011-300364
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje